Author Question: A compact object with a mass of 1.1 solar masses could ____. a. be a neutron star or a black hole ... (Read 90 times)

luminitza

  • Hero Member
  • *****
  • Posts: 555
A compact object with a mass of 1.1 solar masses could ____.
 
  a. be a neutron star or a black hole
 b. be a neutron star, but not a black hole
 c. be a black hole, but not a neutron star
 d. not be a black hole or neutron star
 e. not be a black hole or neutron star

Question 2

Why did Copernicus hesitate to consider alternatives to the Ptolemaic Universe?
 
  a. A heliocentric Universe contradicted Christian theology at the time.
 b. There was no way to prove uniform circular motion.
 c. New star formation showed no parallax.
 d. Most people already believed in a heliocentric Universe.
 e. His mathematics could not disprove Ptolemy's epicycles, deferents and equants.



fromAlphatoOmega22

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

d

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library